Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001140361-23-020315

Director sold 5,000 shares at $20.05 ($100,270)

  • Director acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Chacko Jacob · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-04-21 Exercise or conversion : show line 1 in the form 10b5-1 +5,000 $9.41 $47,050 5,000 D
2023-04-21 Sale : show line 2 in the form 10b5-1 −5,000 $20.05 $100,270 0 D
Open-market sales · 5,000 sh · avg $20.05 · $100,270

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-21 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −5,000 32,500 D
Loading xslF345X04/form4.xml…